Cargando…

Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis

INTRODUCTION: Plasmacytoid variant bladder cancer is a rare variant of urothelial carcinoma that accounts for 1% of bladder cancers. Plasmacytoid variant urothelial carcinoma is characterized by an aggressive phenotype and poor clinical outcomes. CASE PRESENTATION: A 61‐year‐old woman presented with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Yusuke, Tanaka, Satoki, Maruo, Masafumi, Sugawara, Sho, Chiba, Kazuto, Miyazaki, Kanetaka, Inoue, Atsushi, Ichikawa, Tomohiko, Nagata, Maki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249653/ https://www.ncbi.nlm.nih.gov/pubmed/35795120 http://dx.doi.org/10.1002/iju5.12463

Ejemplares similares

Successful treatment of metastatic bladder cancer by gemcitabine‐cisplatin re‐challenge after pembrolizumab
por: Arai, Takayuki, et al.
Publicado: (2021)

Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Todo, Maki, et al.
Publicado: (2019)

A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy
por: Sato, Hiroaki, et al.
Publicado: (2023)

A case of ipsilateral three simultaneous renal cell carcinomas with different histologic types
por: Tanaka, Satoki, et al.
Publicado: (2023)

Impact of novel oncogenic pathways regulated by antitumor miR‐451a in renal cell carcinoma
por: Yamada, Yasutaka, et al.
Publicado: (2018)

Regulation of antitumor miR‐144‐5p targets oncogenes: Direct regulation of syndecan‐3 and its clinical significance
por: Yamada, Yasutaka, et al.
Publicado: (2018)

Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma
por: Yamada, Yasutaka, et al.
Publicado: (2018)

Regulation of NCAPG by miR‐99a‐3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC
por: Arai, Takayuki, et al.
Publicado: (2018)

Plasmacytoid urothelial carcinoma of the bladder: a case report
por: Aldousari, Saad, et al.
Publicado: (2009)

Plasmacytoid bladder cancer: a rare case report
por: Benabdallah, Wajdi, et al.
Publicado: (2023)

Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p
por: Arai, Takayuki, et al.
Publicado: (2018)

Isolated cardiac metastasis from plasmacytoid urothelial carcinoma of the bladder
por: Peck, Joshua R, et al.
Publicado: (2012)

Plasmacytoid urothelial carcinoma of the bladder with extensive scrotal wall invasion
por: Wang, Yong Gang, et al.
Publicado: (2016)

Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma
por: Lockhart, Kathleen, et al.
Publicado: (2021)

Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
por: Sakata, Kei, et al.
Publicado: (2018)

A case of bladder cancer after bilateral lung transplantation following bone marrow transplantation
por: Arai, Yutaro, et al.
Publicado: (2023)

Plasmacytoid Urothelial Carcinoma of the Bladder Metastatic to the Stomach: A Case Report
por: Nabbout, Philippe, et al.
Publicado: (2012)

Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab
por: Shimizu, Takuto, et al.
Publicado: (2020)

Bladder rupture after pembrolizumab immunotherapy for bladder cancer: a case report
por: Badheeb, Ahmed, et al.
Publicado: (2022)

Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data
por: Tsukamoto, Ryo, et al.
Publicado: (2023)

A Case of Urinary Bladder Urothelial Carcinoma with Squamous, Glandular, and Plasmacytoid Differentiation
por: Makise, Naohiro, et al.
Publicado: (2014)

Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report
por: Kohada, Yuki, et al.
Publicado: (2020)

Successful Response of Pembrolizumab Rechallenge after Radiotherapy for a Patient with Bladder Cancer of Nonresponse of Pembrolizumab First Challenge
por: Ikeda, Taro, et al.
Publicado: (2021)

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2017)

A rare case of plasmacytoid urothelial carcinoma of bladder: Diagnostic dilemmas and clinical implications
por: Rahman, Khaliqur, et al.
Publicado: (2011)

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder
por: Kim, Bohyun, et al.
Publicado: (2016)

Plasmacytoid variant of urothelial carcinoma of the bladder manifesting as bilateral ureteral and small bowel obstruction
por: Carsel, Alex, et al.
Publicado: (2020)

Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
por: Nomura, Shunichiro, et al.
Publicado: (2020)

Plasmacytoid Lymphocytes: A Diagnostic Clue for Dengue Fever
por: Tanaka, Yasuhiro
Publicado: (2018)

Pathology quiz case: Plasmacytoid dendritic cell neoplasm
por: Dunlap, Quinn A., et al.
Publicado: (2014)

A case of complete response following the administration of pembrolizumab and metastasectomy for lung and bone metastases of bladder cancer
por: Nakasato, Takehiko, et al.
Publicado: (2021)

An autopsy case of autoimmune meningoencephalitis caused by pembrolizumab
por: Hiraoka, Yuhi, et al.
Publicado: (2022)

Comparison of time to failure of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy: a consecutive analysis of patients having NSCLC with high PD-L1 expression
por: Takumida, Hiroshi, et al.
Publicado: (2021)

Successful treatment of recurrent small cell carcinoma of urinary bladder with pembrolizumab
por: Hatayama, Tomoya, et al.
Publicado: (2020)

Successful treatment of metastatic bladder pleomorphic giant cell carcinoma with pembrolizumab
por: Nezu, Kunihisa, et al.
Publicado: (2021)

Plasmacytoid urothelial carcinoma: a case of histological variant of urinary bladder cancer with aggressive behavior
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Editorial Comment to Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report
por: Hayashi, Tetsutaro, et al.
Publicado: (2020)

Palatal plasmacytoid myoepithelioma
por: Sethi, Divya, et al.
Publicado: (2012)

Pathological Findings of the Host Immune Reaction in the Tumor Microenvironment of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Hasegawa, Sho, et al.
Publicado: (2020)

Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mttqg11vmdm7e9cmfqp2drnnbu